For those marketers reticent to jump on the latest dieting trend, dismissing it as another Atkins or Mediterranean diet, understand that industry experts widely view the impact of GLP-1 medications as a long-term, transformative trend, not a passing fad
Khng theo di tc dng ph : Cc triu chng nh bun nn, to bn hay y bng cn c bo co v iu chnh kp thi bi bc s chuyn khoa m bo qu trnh s dng thuc an ton
Anas Story: From Struggling to Thriving The founder, Ana Reisdorf, MS, RD, knows the journey personally
A 2025 study titled Ocular Adverse Events Associated with GLP-1 Receptor Agonists: A Real-World Study Based on the FAERS Database and Network Pharmacology found that GLP-1 medication was associated with ocular adverse events such as blurred vision, visual impairment, and diabetic retinopathy
The primary objective of our focused review is to illuminate the scientific underpinnings and translational potential of GLP-1R agonists as a foundation for advancing clinical practice and achieving high-level patient care